You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 9,283,178


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,283,178
Title:Methods for treating edema in the eye and intraocular implants for use therefor
Abstract: Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s): Wong; Vernon G. (Menlo Park, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:14/481,778
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patent 9,283,178

To delve into the specifics of U.S. Patent 9,283,178, it is essential to understand the broader context of patent law in the United States, the types of patents, and how patent scope and claims are evaluated.

Overview of U.S. Patent Law

U.S. patent law is governed by the Patent Act (35 U.S. Code) and administered by the United States Patent and Trademark Office (USPTO). The Constitution grants Congress the power to promote science and useful arts by securing exclusive rights to inventors for limited times[1].

Types of Patents

There are several types of patents, including utility patents, design patents, and plant patents. Utility patents, the most common type, protect functional inventions and have a duration of 20 years from the date of filing[1].

Patent Application and Examination Process

To obtain a patent, an applicant must submit a patent application to the USPTO, where it is reviewed by an examiner to determine if the invention is patentable. This process involves a thorough examination to ensure the invention meets the criteria for patentability, including novelty, non-obviousness, and subject matter eligibility[1].

Patent Scope and Claims

Patent scope is a critical aspect of patent law, often measured by metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of patent claims. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Section 101 and Patent-Eligible Subject Matter

Section 101 of the Patent Act defines the types of inventions that may be patented, including processes, machines, manufactures, and compositions of matter. However, judicially developed exceptions exclude certain subject matter, such as abstract ideas, natural phenomena, and laws of nature. The Alice/Mayo framework, established by Supreme Court decisions, further narrows patent-eligible subject matter by requiring that claims must be more than just an abstract idea or a natural phenomenon[5].

Analyzing U.S. Patent 9,283,178

Background and Summary

To analyze U.S. Patent 9,283,178, one would typically start by reviewing the patent's background and summary sections. These sections provide context on the invention, its purpose, and how it addresses existing problems in the field.

Claims

The claims section is the most critical part of a patent, as it defines the scope of the invention. Here, you would look at the independent and dependent claims to understand what is protected. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Description and Drawings

The detailed description and drawings provide a comprehensive explanation of the invention. This section must enable a person skilled in the art to make and use the invention, which is a requirement for patentability[1].

Prior Art and Citations

Reviewing the prior art cited during the examination process can provide insights into how the patent office viewed the novelty and non-obviousness of the invention. Tools like the Common Citation Document (CCD) and the Patent Examination Data System (PEDS) can be useful in this regard[4].

Evaluating Patent Scope

Independent Claim Length and Count

As mentioned earlier, the length and count of independent claims can indicate the breadth of the patent. Narrower claims are often associated with a higher probability of grant and shorter examination times[3].

Alice/Mayo Framework

For patents involving software or abstract ideas, the Alice/Mayo framework is crucial. The patent must pass a two-step test: first, determining if the claim is directed to an abstract idea, natural phenomenon, or law of nature; and second, assessing whether the claim includes an "inventive concept" that transforms the abstract idea into a patent-eligible invention[5].

Impact on Innovation and Industry

The patentability of inventions like those described in U.S. Patent 9,283,178 can significantly impact innovation, especially in emerging technologies. For instance, the 2019 Guidance by the USPTO aimed to clarify the application of the Alice/Mayo framework, which has been seen to increase the allowance rate for AI-related patent applications[5].

Real-World Applications and Examples

Understanding the real-world applications of the patented invention can provide context on its significance. For example, if the patent pertains to a technological advancement in AI, it could have broad implications for industries such as healthcare, finance, and automation.

Challenges and Controversies

Patents, especially those in emerging technologies, often face challenges and controversies. Stakeholders may have differing views on the impact of patent eligibility standards on innovation. For instance, some may argue that current standards hinder innovation in AI, while others see them as necessary to prevent overly broad patents[5].

Key Takeaways

  • Patent Scope: The scope of a patent is crucial and can be measured by metrics such as independent claim length and count.
  • Section 101: The types of inventions that can be patented are defined by Section 101, with judicially developed exceptions narrowing the scope.
  • Alice/Mayo Framework: This framework is essential for determining the patent eligibility of inventions involving abstract ideas.
  • Impact on Innovation: Patent eligibility standards can significantly affect innovation, particularly in emerging technologies.
  • Real-World Applications: Understanding the practical applications of a patented invention is vital for assessing its impact.

FAQs

What is the purpose of the Alice/Mayo framework in patent law?

The Alice/Mayo framework is used to determine the patent eligibility of inventions, particularly those involving abstract ideas, by ensuring they include an "inventive concept" that transforms the abstract idea into a patent-eligible invention[5].

How do independent claim length and count affect patent scope?

Narrower claims, as indicated by shorter independent claim length and lower independent claim count, are associated with a higher probability of grant and shorter examination times[3].

What types of patents are most common in the United States?

Utility patents are the most common type of patent in the United States, protecting functional inventions for a duration of 20 years from the date of filing[1].

How does the USPTO evaluate patent applications?

The USPTO evaluates patent applications through a thorough examination process to ensure the invention meets criteria for novelty, non-obviousness, and subject matter eligibility[1].

What is the significance of the 2019 Guidance by the USPTO?

The 2019 Guidance by the USPTO aimed to clarify the application of the Alice/Mayo framework, leading to an increase in the allowance rate for patent applications containing AI and other computer-related inventions[5].

Cited Sources

  1. BitLaw: "Patent Law in the United States" - Summary and Detailed Explanations of Patent Law[1].
  2. USAGov: "U.S. Patent and Trademark Office (USPTO)" - Agency responsible for granting U.S. patents and registering trademarks[2].
  3. SSRN: "Patent Claims and Patent Scope" - Metrics for measuring patent scope based on claim language[3].
  4. USPTO: "Search for patents" - Tools and services for searching and analyzing patent data[4].
  5. CRS Reports: "Patent-Eligible Subject Matter Reform: An Overview" - Analysis of recent judicial, administrative, and legislative developments related to patent-eligible subject matter[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,283,178

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,283,178

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 306951 ⤷  Subscribe
Australia 2002236495 ⤷  Subscribe
Australia 2006201271 ⤷  Subscribe
Australia 3649502 ⤷  Subscribe
Brazil 0115772 ⤷  Subscribe
Canada 2429998 ⤷  Subscribe
Germany 60114229 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.